Impact News +++ Entera Bio GAAP EPS of -$0.25 beats by $0.03, revenue of $0.04M in-line (SeekingAlpha) +++ ENTERA BIO Aktie +4,90%

OPKO HEALTH Aktie

>OPKO HEALTH Aktienkurs

0.977 EUR (TradegateBSX)

Ask: 0.992 EUR / 3025 Stück

Bid: 0.963 EUR / 3113 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

OPKO HEALTH Aktie über LYNX handeln

Intraday

1 Jahr

>OPKO HEALTH Performance

1 Woche: -2,2%

1 Monat: -4,9%

3 Monate: -12,4%

6 Monate: -21,4%

1 Jahr: -39,0%

laufendes Jahr: -11,2%

>OPKO HEALTH Aktie

Name:

OPKO HEALTH INC. DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US68375N1037 / A0MUUJ

Symbol/ Ticker:

XCY (Frankfurt) / OPK (NASDAQ)

Kürzel:

FRA:XCY, ETR:XCY, XCY:GR, NASDAQ:OPK

Index:

Webseite:

https://www.opko.com/

Profil:

OpKO Health Inc. is a multinational biopharmaceutical and diagnostics company operating through two primary segments: Pharmaceuticals and Diagnostics. In the Pharmaceuticals segment, it develops and c..
>Volltext..

Marktkapitalisierung:

738.79 Mio. EUR

Unternehmenswert:

762.42 Mio. EUR

Umsatz:

527.38 Mio. EUR

EBITDA:

-110.68 Mio. EUR

Nettogewinn:

-196.12 Mio. EUR

Gewinn je Aktie:

-0.26 EUR

Schulden:

344.8 Mio. EUR

Liquide Mittel:

320.73 Mio. EUR

Operativer Cashflow:

-155.15 Mio. EUR

Bargeldquote:

2.52

Umsatzwachstum:

-24.99%

Gewinnwachstum:

-273.54%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

1 Insider kaufte innerhalb der letzten 30 Tage Aktien im Wert von 11.350 USD.

Suchwörter:

OPKO HEALTH

Letzte Datenerhebung:

28.03.26

>OPKO HEALTH Kennzahlen

Aktien/ Unternehmen:

Aktien: 759.07 Mio. St.

Frei handelbar: 50.94%

Leerverk. Aktien: 4.32%

Rückkaufquote: 5.56%

Mitarbeiter: 2275

Umsatz/Mitarb.: 0.23 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 195.22%

Bewertung:

KGV: -

KGV lG: -

KUV: 1.49

KBV: 0.69

PEG-Ratio: -0.02

EV/EBITDA: -

Rentabilität:

Bruttomarge: 21.1%

Gewinnmarge: -37.19%

Operative Marge: -36.08%

Managementeffizenz:

Gesamtkaprendite: -10.92%

Eigenkaprendite: -17.14%

>OPKO HEALTH Peer Group

Gesundheit, Onkologie/ Krebs- Behandlung, Nierenerkrankungen & -behandlung

>OPKO HEALTH Chart & Kurs - NASDAQ

>OPKO HEALTH News

21.03.26 - 01:01	Insiderhandel: Aufsichtsrat kauft Aktien von Opko Health im Wert von 11350 USD (Insiderkauf)
	Paganelli, John A. - Aufsichtsrat - Tag der Transaktion: 2026-03-20...

27.02.26 - 20:31	OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts (Zacks)
	OPKO Health beats Q4 earnings and revenue estimates, but sales decline and gross margin narrows....

27.02.26 - 14:03	OPKO Health to Participate in the Jefferies Biotech on the Beach Summit (GlobeNewswire EN)
	MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11, 2026, at 1 Hotel South Beach in Miami. Management will be holding one-on-one meetings with investors registered for the event on Wednesday, March 11th....

27.02.26 - 03:00	OPKO Health (OPK) Q4 2025 Earnings Call Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

27.02.26 - 02:30	OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
	OPKO Health (OPK) delivered earnings and revenue surprises of +39.39% and +7.56%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...

27.02.26 - 02:30	Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics (Zacks)
	While the top- and bottom-line numbers for OPKO Health (OPK) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....

26.02.26 - 23:42	OPKO Health: Gewinnprognose für Q4 2025 übertroffen, Aktie dennoch im Minus (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

26.02.26 - 22:09	OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results (GlobeNewswire EN)
	Conference call begins at 4:30 p.m. Eastern time today Conference call begins at 4:30 p.m. Eastern time today...

18.02.26 - 18:15	Can OPKO Health′s Pipeline Progress and Deals Drive Growth in 2026? (Zacks)
	OPKO Health targets 30% growth in fiscal 2026, driven by RAYALDEE sales, strategic deals and pipeline progress, despite competitive pressures and reliance risks...

12.02.26 - 14:03

OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 (GlobeNewswire EN)

MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on Thursday, February 26, 2026. OPKO's senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast beginning at 4:30 p.m. Eastern time....

04.02.26 - 14:06	OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism (GlobeNewswire EN)
	This is the third program that successfully combines Entera's oral peptide N-Tab® platform with OPKO's advanced protein chemistry capabilities...

06.01.26 - 22:15

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire EN)

MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 44th Annual J.P. Morgan Healthcare Conference, being held January 12-15, 2026, at the Westin St. Francis Hotel in San Francisco. Management will be hosting one-on-one meetings with investors and will be participating in a fireside chat on Wednesday, January 14th at 1:30 p.m. Pacific time....

06.01.26 - 14:30	OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth (Zacks)
	OPK leans on RAYALDEE momentum and strategic partnerships as pipeline trials advance, though reliance on its lone U.S. drug adds risk....

09.12.25 - 15:01	Here′s Why You Should Retain OPKO Health Stock in Your Portfolio Now (Zacks)
	OPK leans on RAYALDEE momentum and strategic partnerships as pipeline trials advance, though reliance on its lone U.S. drug adds risk....

22.11.25 - 03:01	Insiderhandel: CEO & Chairman kauft Aktien von Opko Health im Wert von 768807 USD (Insiderkauf)
	Frost, Phillip Md Et Al - Vorstand - Tag der Transaktion: 2025-11-21...

21.11.25 - 03:01	Insiderhandel: CEO & Chairman kauft Aktien von Opko Health im Wert von 771327 USD (Insiderkauf)
	Frost, Phillip Md Et Al - Vorstand - Tag der Transaktion: 2025-11-20...

20.11.25 - 02:02	Insiderhandel: CEO & Chairman kauft Aktien von Opko Health im Wert von 759117 USD (Insiderkauf)
	Frost, Phillip Md Et Al - Vorstand - Tag der Transaktion: 2025-11-19...

19.11.25 - 22:09

OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire EN)

MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 37th Annual Healthcare Conference, being held December 2-4, 2025 at the Lotte New York Palace Hotel in New York City. Management will be holding one-on-one meetings with investors and will be participating in a fireside discussion on Wednesday, December 3rd at 12:00 p.m. Eastern time....

19.11.25 - 00:02	Insiderhandel: CEO & Chairman kauft Aktien von Opko Health im Wert von 678905 USD (Insiderkauf)
	Frost, Phillip Md Et Al - Vorstand - Tag der Transaktion: 2025-11-18...

01.11.25 - 02:01	Insiderhandel: CEO & Chairman kauft Aktien von Opko Health im Wert von 213435 USD (Insiderkauf)
	Frost, Phillip Md Et Al - Vorstand - Tag der Transaktion: 2025-10-31...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Am meisten Platz ist zu Hause. - Sprichwort Serbien

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram